The Brazilian Patent and Trademark Office (BPTO) launches a PPH Pilot Program with the European Patent Office (EPO) -

October 16, 2017

The Brazilian Patent and Trademark Office (BPTO) launches a PPH Pilot Program with the European Patent Office (EPO)

This time, the measure consists of a cooperation agreement signed between the BPTO and the EPO by means of a PPH (Patent Prosecution Highway) Pilot Program exclusively directed to inventions in the Medical Technology and the Chemistry areas (excluding pharmaceutical products).

The new program will accept a maximum of 300 applications per year, whose examinations will be accelerated after the grant of the corresponding patents by the EPO.

Nowadays, Brazil already maintains PPH agreements with USA (Oil & Gas), Japan (information technology and mechanical engineering) and Latin-America countries that are members of Prosur.

Should you wish to receive more information on this subject, please do not hesitate to contact us, by e-mail or telephone, directly with your usual contact at our office or by e-mail at mail@kasznarleonardos.com

Back

Last related news

November 14, 2022

Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

On November 8, 2022, the Brazilian Data Protection Authority (“Authority”) published its 2023-2024 Regulatory Agenda (“Current Agenda”), establishing high-priority topics over the … Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

November 10, 2022

Bill creates Legal Framework for the Electronic Games Industry in Brazil

On October 19, 2022, the Brazilian House of Representatives approved Bill No. 2.796/2021 that creates a legal framework for the Brazilian gaming … Bill creates Legal Framework for the Electronic Games Industry in Brazil

October 20, 2022

CFM updates its Resolution on cannabidiol prescription and use

The Federal Council of Medicine (CFM) published, on 10/14/2022, CFM Resolution No. 2,324/22, which authorizes the use of cannabidiol (CBD) for treatment … CFM updates its Resolution on cannabidiol prescription and use

Simone Grizzo Bösenberg

Newsletter